Qiagen NV at Evercore ISI HealthCONx Virtual Conference Transcript
Okay. Thanks, everyone, for joining us this morning. I'm Vijay Kumar. I cover Life Science Tools and MedTech at Evercore. Pleasure to have with us at QIAGEN. We have with us Roland Sackers, the CFO. I think I might have John Gilardi as well on. There he is. I could see John waving out there.
It's always -- QIAGEN has been near and dear, it was for a variety of reasons over the years. It's -- unfortunately, we couldn't be part of the story for the last couple of years, but it's certainly been exciting for you guys.
Questions & Answers
From a far, Roland, when I think about the story, what the debate was 3 years ago versus now, it's changed. So I do want to dive in some of these things. But before I ask on the fundamentals, what's changed, maybe perhaps a lot of questions, can diagnostic companies detect a new Omicron variant? So maybe talk about whether your test
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
